Immunology investors
7 investors that name Immunology among their sectors are recorded here: 5 venture capital firms, 1 accelerator and 1 corporate venture arm. Stated investment stages run from pre-seed to growth. Most are headquartered in the United States (3), Switzerland (1) and Italy (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Agent Capital, LLC Rare Diseases · Oncology · Neurology · Immunology |
Direct investor | Venture capital | Seed – Growth | Waltham, United States |
| Atlas Venture biotechnology · life sciences · therapeutics · gene therapy |
Direct investor | Venture capital | Seed – Series A | Cambridge, United States |
| BaseLaunch biotech · therapeutics · oncology · immunology |
Direct investor | Accelerator | Pre-seed – Series A | Basel, Switzerland |
| Claris Ventures biopharma · oncology · immunology · rare diseases |
Direct investor | Venture capital | Pre-seed – Series A | Turin, Italy |
| Johnson & Johnson Innovation – JJDC pharmaceuticals · medtech · oncology · immunology |
Direct investor | Corporate venture | Seed – Growth | |
| MPM BioImpact biotechnology · drug development · oncology · immunology |
Direct investor | Venture capital | Seed – Growth | Boston, United States |
| TVM Capital Life Science therapeutics · medtech · diagnostics · digital health |
Direct investor | Venture capital | Seed – Growth |